Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-05-18

Clinical Trial Update: Placebo-Controlled Therapeutic Trial for the Prevention of Lymphedema [NA]

View source ↗

Summary

This clinical trial evaluated a therapy to prevent lymphedema using a placebo-controlled design. It was terminated, and results were posted on May 18, 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Stanford University | Conditions: Lymphedema, Unspecified Adult Solid Tumor, Protocol Specific | NA | Status: TERMINATED | Results posted: 2017-05-18